Didecyldimethylammonium PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
20256-56-8
Molecular formula
C22H48N+
Molecular weight
326.6 g/mol
Drug class
Quaternary ammonium cationic surfactantdisinfectant and biocidal active ingredient
Mechanism of action
Disrupts microbial cell membranes by adsorbing to membrane phospholipids and increasing permeability, causing leakage of intracellular contents. It is predominantly used in surface disinfectants and biocidal formulations.
Indications / reported uses
Disinfection of environmental surfaces, equipment and selected hard surfaces in authorised biocidal products; not a systemic human therapeutic API indication
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Didecyldimethylammonium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Didecyldimethylammonium Permitted Daily Exposure (PDE) report (the Didecyldimethylammonium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Didecyldimethylammonium Occupational Exposure Limit (OEL) report (the Didecyldimethylammonium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.